6MHM image
Entry Detail
PDB ID:
6MHM
Keywords:
Title:
Crystal structure of human acid ceramidase in covalent complex with carmofur
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2018-09-18
Release Date:
2019-01-23
Method Details:
Experimental Method:
Resolution:
2.74 Å
R-Value Free:
0.26
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Acid ceramidase subunit alpha
Chain IDs:A, C
Chain Length:131
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Acid ceramidase subunit beta
Chain IDs:B, D
Chain Length:253
Number of Molecules:2
Biological Source:Homo sapiens
Peptide-like Molecules
PRD_900017
Primary Citation
Molecular Mechanism of Inhibition of Acid Ceramidase by Carmofur.
J. Med. Chem. 62 987 992 (2019)
PMID: 30525581 DOI: 10.1021/acs.jmedchem.8b01723

Abstact

Human acid ceramidase (AC) is a lysosomal cysteine amidase, which has received a great deal of interest in recent years as a potential target for the development of new therapeutics against melanoma and glioblastoma tumors. Despite the strong interest in obtaining structural information, only the structures of the apo-AC enzyme in its zymogen and activated conformations are available. In this work, the crystal structure of AC in complex with the covalent carmofur inhibitor is presented. Carmofur is an antineoplastic drug containing an electrophilic carbonyl reactive group that targets the catalytic cysteine. This novel structural data explains the basis of the AC inhibition, provides insights into the enzymatic properties of the protein, and is a great aid toward the structure-based drug design of potent inhibitors for AC, providing the detailed mechanism, which has eluded the scientific community for more than 30 years, of carmofur's mysterious 5-fluorouracil-independent antitumor activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures